Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Feb;24(1):8-9.
doi: 10.1089/pop.2020.0134. Epub 2020 Jun 29.

Consequences of the COVID-19 Pandemic: Reduced Hemoglobin A1c Diabetes Monitoring

Maren S Fragala  1 , Harvey W Kaufman  1 , James B Meigs  2   3 , Justin K Niles  1 , Michael J McPhaul  4
Affiliations

Consequences of the COVID-19 Pandemic: Reduced Hemoglobin A1c Diabetes Monitoring

Maren S Fragala et al. Popul Health Manag. 2021 Feb.
No abstract available

Keywords: COVID-19; diabetes; hemoglobin A1c testing.

PubMed Disclaimer

Conflict of interest statement

Drs. Fragala, Kaufman, and McPhaul are employees of Quest Diagnostics and own stock in the company. Mr. Niles is an employee of Quest Diagnostics. Dr. Meigs is an academic associate for Quest Diagnostics.

Figures

FIG. 1.
FIG. 1.
Weekly hemoglobin A1c testing among patients presumed to have diabetes, by sex and age groups. Black bar represents the average of baseline weekly testing volume for 60 weeks prior to March 1, 2020, for the various sex and age groupings. The numbers at the top of the chart are the baseline weekly testing volumes. The x-axis is volume in successive weeks (week 1–8) relative to baseline; March 1–7 is week 1. The y-axis depicts the weekly volumes for each category relative to the baseline weekly test volumes in percentage terms.
See this image and copyright information in PMC

References

    1. Karter AJ, Parker MM, Moffet HH, et al. . Missed appointments and poor glycemic control: an opportunity to identify high-risk diabetic patients. Med Care 2004;42:110–115 - PubMed
    1. Samuels TA, Bolen S, Yeh HC, et al. . Missed opportunities in diabetes management: a longitudinal assessment of factors associated with sub-optimal quality. J Gen Intern Med 2008;23:1770–1777 - PMC - PubMed
    1. Stratton IM, Adler AI, Neil HA, et al. . Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ 2000;321:405–412 - PMC - PubMed
    1. Gilmer TP, O'Connor PJ, Rush WA, et al. . Predictors of health care costs in adults with diabetes. Diabetes Care 2005;28:59–64 - PubMed
    1. Fitch K, Pyenson BS, Iwasaki K. Medical claim cost impact of improved diabetes control for Medicare and commercially insured patients with type 2 diabetes. J Manag Care Pharm 2013;19:609–620, 620a–620d. - PMC - PubMed

Substances

LinkOut - more resources